Search results for " tuberculosis"

showing 10 items of 213 documents

Burkitt lymphoma associated with human immunodeficiency virus infection and pulmonary tuberculosis: A case report.

2019

Abstract Introduction: The association of human immunodeficiency virus (HIV) infection with Burkitt lymphoma is related to the presence of Epstein Barr virus infection and the impact of the HIV antigen on the expansion of B-polyclonal cells. In Southeast Europe, the association is rare, and recognizing this is important in the therapeutic decision to increase patient survival rate. The association of HIV with Burkitt lymphoma and tuberculosis is even more rarely described in the literature. Patient concerns: We present the case of a 40-year-old patient who presented with a 3-week history of fever (max. 38.7 °C), painful axillary swelling on the right side, lumbar pain, gait disorders, heada…

AdultMalemedicine.medical_specialtyTuberculosisAntitubercular AgentsAntineoplastic AgentsHIV Infectionshuman immunodeficiency virus infectionNeurosurgical ProceduresMycobacterium tuberculosis03 medical and health sciences0302 clinical medicinePharmacotherapyFatal Outcomeimmune system diseasesInternal medicinehemic and lymphatic diseasesAntiretroviral Therapy Highly ActivemedicineHumans030212 general & internal medicineClinical Case ReportEpstein–Barr virus infectionTuberculosis PulmonaryImmunodeficiencydose-adjusted etoposide doxorubicin and cyclophosphamide with vincristine prednisone and rituximabbiologyClinical Deteriorationbusiness.industry4900BrainBurkitt lymphomaGeneral MedicineViral Loadhighly active antiretroviral therapymedicine.diseasebiology.organism_classificationDecompression SurgicalLymphomaCD4 Lymphocyte CountSpinal Cord030220 oncology & carcinogenesisSputummedicine.symptombusinessViral loadpulmonary tuberculosisResearch ArticleMedicine
researchProduct

New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response

2009

Abstract Background Interferon-gamma (IFN-γ) release assays (IGRAs) were designed to detect latent tuberculosis infection (LTBI). However, discrepancies were found between the tuberculin skin test (TST) and IGRAs results that cannot be attributed to prior Bacille Calmètte Guerin vaccinations. The aim of this study was to evaluate tools for improving LTBI diagnosis by analyzing the IFN-γ response to RD1 proteins in prolonged (long-term response) whole blood tests in those subjects resulting negative to assays such as QuantiFERON-TB Gold In tube (QFT-IT). Methods The study population included 106 healthy TST+ individuals with suspected LTBI (recent contact of smear-positive TB and homeless) c…

AdultMalemedicine.medical_specialtyTuberculosisTuberculinlcsh:Infectious and parasitic diseasesMycobacterium tuberculosisInterferon-gammaYoung AdultMedical microbiologyAntigenLatent TuberculosismedicineHumanslcsh:RC109-216tuberculosis latent infection IGRA testAntigens BacterialLatent tuberculosisbiologyTuberculin Testbusiness.industryMycobacterium tuberculosisMiddle Agedmedicine.diseasebiology.organism_classificationbacterial infections and mycosesVaccinationLong term responseInfectious DiseasesImmunologyFemaleReagent Kits DiagnosticbusinessResearch ArticleBMC Infectious Diseases
researchProduct

Tuberculous aortitis in an human immunodeficiency virus-positive Ivorian migrant: A case report.

2021

We report an unusual case of a 35-year-old Ivorian migrant with an abdominal mass and medical history relevant for human immunodeficiency virus-2 positivity with a CD4/CD8 ratio of 0.63; Mantoux and lymphocyte stimulation tests (QuantiFERON) were positive. 3D-CT images revealed a voluminous non-homogeneous retroperitoneal mass in the right abdominal region presenting no significant contrast impregnation. Thoraco-abdominal aorta presented diffuse-altered morphology with multiple ectasias throughout its course and an aneurysm at the level of the subrenal tract. The patient underwent vascular surgery. Mycobacterium tuberculosis complex was detected by polymerase chain reaction performed on in…

Adultmedicine.medical_specialtyDermatologyQuantiFERONAneurysmTuberculous aortitisEctasiamedicinecase reportHumansTuberculosisPharmacology (medical)Medical history3D reconstructionextrapulmonary tuberculosiAortitisTransients and MigrantsbiologyAortitisbusiness.industryhuman immunodeficiency viruPublic Health Environmental and Occupational HealthHIVVascular surgerymedicine.diseasebiology.organism_classificationAbdominal massInfectious DiseasesCote d'IvoireMycobacterium tuberculosis complexRadiologymedicine.symptombusinessInternational journal of STDAIDS
researchProduct

Missed opportunities for tuberculosis investigation in a municipal hospital in Ghana: evidence from patient exit interviews

2020

Abstract Background We assessed coverage of symptom screening and sputum testing for tuberculosis (TB) in hospital outpatient clinics in Ghana. Methods In a cross-sectional study, we enrolled adults (≥18 years) exiting the clinics reporting ≥1 TB symptom (cough, fever, night sweats or weight loss). Participants reporting a cough ≥2 weeks or a cough of any duration plus ≥2 other TB symptoms (per national criteria) and those self-reporting HIV-positive status were asked to give sputum for testing with Xpert MTB/RIF. Results We enrolled 581 participants (median age 33 years [IQR: 24–48], 510/581 [87.8%] female). The most common symptoms were fever (348, 59.9%), chest pain (282, 48.5%) and coug…

Adultmedicine.medical_specialtyTuberculosisHIV InfectionsChest painGhanaSensitivity and SpecificitySputum testingWeight lossInternal medicinemedicineHumansTuberculosisOutpatient clinicHospitals Municipalbusiness.industrySputumPublic Health Environmental and Occupational HealthMycobacterium tuberculosisGeneral MedicineOdds ratiomedicine.diseaseConfidence intervalCross-Sectional StudiesInfectious DiseasesSputumFemaleParasitologymedicine.symptombusinessTransactions of The Royal Society of Tropical Medicine and Hygiene
researchProduct

Role of antibodies in vaccine-mediated protection against tuberculosis.

2022

Antibodies.Settore MED/04 - Patologia GeneraleAntigens BacterialInfectious DiseasesTuberculosiImmunologyImmunology and AllergyHumansTuberculosisMycobacterium tuberculosisTuberculosis VaccinesAntibodies BacterialVaccine
researchProduct

Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8(+) T lymphocytes.

2002

CD8(+) T cells could make an important contribution to protection against tuberculosis (TB), but the antigenic determinants recognized in the context of major histocompatibility complex class I molecules remain ill defined. Our aim was to identify nonamer peptides derived from the acr/16-kDa antigen. Two immunogenic peptides (p21-29 and p120-128) were identified by their ability to elicit cytotoxic CD8(+) T cells from juvenile patients recovering from TB. Epitope-specific recognition was demonstrated by the lysis of both Mycobacterium tuberculosis-infected and peptide-pulsed macrophages, the release of cytotoxic granules, and interferon-gamma and tumor necrosis factor-alpha production. CD8(…

Antigens Differentiation T-LymphocyteCytotoxicity ImmunologicMalePore Forming Cytotoxic ProteinsT cellEpitopes T-LymphocyteHuman leukocyte antigenCD8-Positive T-LymphocytesMajor histocompatibility complexEpitopeInterferon-gammaImmune systemAntigenBacterial ProteinsHLA-A2 AntigenmedicineImmunology and AllergyCytotoxic T cellHumansChildTuberculosis PulmonaryMembrane GlycoproteinsbiologyHLA-A AntigensPerforinTumor Necrosis Factor-alphaMacrophagesMycobacterium tuberculosisFlow CytometryPeptide FragmentsMolecular WeightInfectious Diseasesmedicine.anatomical_structureImmunologybiology.proteinFemaleCD8The Journal of infectious diseases
researchProduct

Granulysin‐Dependent Killing of Intracellular and ExtracellularMycobacterium tuberculosisby Vγ9/Vδ2 T Lymphocytes

2001

Contribution of Vgamma9/Vdelta2 T lymphocytes to immune protection against Mycobacterium tuberculosis is still a matter of debate. It was reported earlier that Vgamma9/Vdelta2 T lymphocytes kill macrophages harboring live M. tuberculosis through a granule-dependent mechanism that results in killing of intracellular bacilli. This study found that Vgamma9/Vdelta2 T lymphocytes reduce the viability of both extracellular and intracellular M. tuberculosis. Granulysin and perforin, both detected in Vgamma9/Vdelta2 T lymphocytes, play a major role, which indicates that Vgamma9/Vdelta2 T lymphocytes directly contribute to a protective host response against M. tuberculosis infection.

Antigens Differentiation T-LymphocyteCytotoxicity ImmunologicTuberculosisReceptors Antigen T-Cell alpha-betaT-LymphocytesBiologyMicrobiologyMycobacterium tuberculosisExtracellularmedicineHumansTuberculosisImmunology and AllergyMacrophageGranulysinMacrophagesReceptors Antigen T-Cell gamma-deltaMycobacterium tuberculosisT lymphocytemedicine.diseasebiology.organism_classificationInfectious DiseasesPerforinImmunologybiology.proteinIntracellularThe Journal of Infectious Diseases
researchProduct

Selective depression of interferon-γ and granulysin production with increase of proliferative response by Vγ9/Vδ2 T cells in children with tuberculos…

2002

Vgamma9/Vdelta2 T cells can contribute to protective immune response against Mycobacterium tuberculosis, although the extent to which and mechanisms by which they could actually protect against human tuberculosis remain unclear. We have previously reported that Vgamma9/Vdelta2 T cells from tuberculin purified protein derivative (PPD)-positive children, either healthy or affected by different clinical forms of tuberculosis, strongly proliferate to different phosphoantigens in vitro, whereas Vgamma9/Vdelta2 T cells from PPD-negative healthy subjects proliferate very poorly. We report here that Vgamma9/Vdelta2 T cells from tuberculous children have an increased proliferative activity, but decr…

Antigens Differentiation T-LymphocyteMaleAdolescentTuberculosiT cellT-LymphocytesAntitubercular AgentsMycobacterium tuberculosis.BiologyMycobacterium tuberculosisAntitubercular AgentInterferon-gammaImmune systemAntigenmedicineImmunology and AllergyCytotoxic T cellHumansTuberculosisInterferon gammaGranulysinChildTuberculin TestInfantReceptors Antigen T-Cell gamma-deltaMycobacterium tuberculosisbiology.organism_classificationInfectious Diseasesmedicine.anatomical_structureGranulysin productionT-LymphocyteChild PreschoolImmunologyFemalemedicine.drugHuman
researchProduct

Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy

2007

Abstract Granulysin is a cytolytic protein of natural killer (NK) cells and cytotoxic T lymphocytes (CTLs). Serum levels of granulysin are related to host cellular immunity. We used an ELISA to quantify granulysin serum levels in children with tuberculosis (TB), before and after chemotherapy. The study involved children affected by different clinical forms of TB (n=72) and healthy control children (n=150) from the same geographical area and of similar socio-economic background. Serum granulysin levels before the initiation of TB therapy were significantly lower in children with TB compared to controls, with the lowest levels being found in TB patients who were PPD skin test negative. No sta…

Antigens Differentiation T-LymphocyteMaleMicrobiology (medical)Cellular immunityTuberculosisTuberculosimedicine.medical_treatmentImmunologyAntitubercular AgentsMicrobiologyArticleDisease activityAntigenSerum granulysinmedicineHumansTuberculosisCytotoxic T cellDisease activityGranulysinChildTuberculosis PulmonaryChildhood tuberculosisChemotherapybusiness.industrymedicine.diseaseCoculture TechniquesInfectious DiseasesChild PreschoolTuberculosis MeningealImmunologyFemaleTherapybusinessBiomarkersTuberculosis
researchProduct

Flavonoids from Erythrina schliebenii

2017

Prenylated and O-methylflavonoids including one new pterocarpan (1), three new isoflavones (2–4), and nineteen known natural products (5–23) were isolated and identified from the root, stem bark, and leaf extracts of Erythrina schliebenii. The crude extracts and their constituents were evaluated for antitubercular activity against Mycobacterium tuberculosis (H37Rv strain), showing MICs of 32–64 μg mL–1 and 36.9–101.8 μM, respectively. Evaluation of their toxicity against the aggressive human breast cancer cell line MDA-MB-231 indicated EC50 values of 13.0–290.6 μM (pure compounds) and 38.3 to >100 μg mL–1 (crude extracts).

Antitubercular AgentsPharmaceutical ScienceMicrobial Sensitivity TestsPlant RootsTanzania01 natural sciencesErythrina schliebeniiAnalytical ChemistryMycobacterium tuberculosischemistry.chemical_compoundDrug DiscoveryBotanyHumansta116Nuclear Magnetic Resonance BiomolecularErythrinaEC50FlavonoidsPharmacologyStem barkMolecular StructureTraditional medicinebiology010405 organic chemistryOrganic ChemistryErythrina schliebeniiPterocarpanMycobacterium tuberculosisIsoflavonesbiology.organism_classification0104 chemical sciences3. Good health010404 medicinal & biomolecular chemistryComplementary and alternative medicinechemistryToxicityPlant BarkMolecular MedicineDrug Screening Assays AntitumorCancer cell linesJournal of Natural Products
researchProduct